1 chimera NL4-3 EnvLuc/VSV-G pseudotype, washed 3 times, and then treated with increasing concentrations of SP4-2, for 24 h. Intracellular luciferase gene marker expression was quantified from cell lysates that were normalized to the same number of viable cells by the MTT assay, and percent inhibition of HIV-1 replication was calculated from a control cell culture of infected but untreated cells, and plotted on the y-axis. (B) Standard cell free fluorescent RT assay was performed in the presence of 2 units recombinant HIV-1 RT/reaction with the indicated concentrations of SP4-2. Percent inhibition was calculated comparative to assay performed in absence of treatment, 100% RT activity. Data are mean ± SD of three separate experiments.<p><b>C...
<p>(A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GF...
<p>(A) Amount of produced virus measured by p24 production: Persistently HIV-1-infected ACH-2 cells ...
<p>Inhibition of HIV-1 infection by PS extract was enhanced by pre-incubation of virus preparations ...
10M ddC, or mock treated (0 μg SP4-2), as indicated. Then, cells were infected with HIV-1 (NL4-3) at...
10M ddC, or mock treated (0 μg SP4-2), as indicated. Then, cells were infected with HIV-1 (NL4-3) at...
Incubated at 37°C in COatmosphere with increasing concentrations of SP4-2, as indicated, then infect...
M-Vpr-X4-tropic NL4-3, or (C) infected in the presence of 10 μg/ml SP4-2, or (D) infected in the pre...
Tmosphere with increasing concentrations of SP4-2 for 1.5 hours prior to infection. Treatment was wa...
doi:10.3791/51400 (2014). Although a number of anti HIV drugs have been approved, there are still pr...
Assessing the actual efficacy of compounds to directly inhibit HIV reverse transcriptase (RT) activi...
<p><i>A</i>, Comparison of time-of-addition (TOA) profiles of PS extract and reference compounds tha...
<p>A. Inhibition of HIV-1<sub>NL4-3</sub> Env-pseudotyped virus in single-cycle assay that demonstra...
Abstract Background Most in vitro assays of drug potency may not adequately predict the performance ...
During HIV-1 reverse transcription, there are increasing opportunities for nucleos(t)ide (NRTI) or n...
This study describes a novel, PCR-based assay that evaluates the ability of compounds to inhibit c...
<p>(A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GF...
<p>(A) Amount of produced virus measured by p24 production: Persistently HIV-1-infected ACH-2 cells ...
<p>Inhibition of HIV-1 infection by PS extract was enhanced by pre-incubation of virus preparations ...
10M ddC, or mock treated (0 μg SP4-2), as indicated. Then, cells were infected with HIV-1 (NL4-3) at...
10M ddC, or mock treated (0 μg SP4-2), as indicated. Then, cells were infected with HIV-1 (NL4-3) at...
Incubated at 37°C in COatmosphere with increasing concentrations of SP4-2, as indicated, then infect...
M-Vpr-X4-tropic NL4-3, or (C) infected in the presence of 10 μg/ml SP4-2, or (D) infected in the pre...
Tmosphere with increasing concentrations of SP4-2 for 1.5 hours prior to infection. Treatment was wa...
doi:10.3791/51400 (2014). Although a number of anti HIV drugs have been approved, there are still pr...
Assessing the actual efficacy of compounds to directly inhibit HIV reverse transcriptase (RT) activi...
<p><i>A</i>, Comparison of time-of-addition (TOA) profiles of PS extract and reference compounds tha...
<p>A. Inhibition of HIV-1<sub>NL4-3</sub> Env-pseudotyped virus in single-cycle assay that demonstra...
Abstract Background Most in vitro assays of drug potency may not adequately predict the performance ...
During HIV-1 reverse transcription, there are increasing opportunities for nucleos(t)ide (NRTI) or n...
This study describes a novel, PCR-based assay that evaluates the ability of compounds to inhibit c...
<p>(A) Titration of PF74 or indicated derivatives onto HeLa cells infected with VSV-G pseudotyped GF...
<p>(A) Amount of produced virus measured by p24 production: Persistently HIV-1-infected ACH-2 cells ...
<p>Inhibition of HIV-1 infection by PS extract was enhanced by pre-incubation of virus preparations ...